Paper Details
- Home
- Paper Details
9-cis-retinoic acid improves sensitivity to platelet-derived growth factor-BB via RXRα and SHP-1 in diabetic retinopathy.
Author: ChenYu, LiWenjie, LiuFen, TangLuosheng, TangRenhong, WangWen
Original Abstract of the Article :
Diabetic retinopathy (DR) is one of the most common complications of diabetes mellitus. But few efficient therapeutic methods have been reported. This study discussed the functions of 9-cis-retinoic acid (9-cis-RA) in sensitizing retinal pericytes to platelet-derived growth factor (PDGF)-BB. Using s...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/j.bbrc.2015.08.093
データ提供:米国国立医学図書館(NLM)
9-cis-Retinoic Acid: A Potential Treatment for Diabetic Retinopathy
In the challenging realm of [diabetic retinopathy (DR)], a leading cause of [vision loss] in diabetic patients, researchers are constantly seeking new and effective therapies. This study explores the potential role of [9-cis-retinoic acid (9-cis-RA)] in [sensitizing retinal pericytes] to [platelet-derived growth factor (PDGF)-BB], a vital signaling molecule that plays a crucial role in [retinal blood vessel health]. The authors investigated the effects of 9-cis-RA in both [diabetic mice and high glucose-treated retinal pericytes], finding that it significantly [inhibited the expression of SHP-1], a protein that can [dampen PDGF-BB signaling]. This, in turn, [enhanced PDGF-BB sensitivity] and [reduced cell apoptosis], suggesting that 9-cis-RA could potentially [protect retinal pericytes] from the damaging effects of [high glucose] in DR. This research is like a desert traveler discovering a precious oasis, offering a potential source of hope in the fight against a debilitating disease.Unveiling the Potential of 9-cis-Retinoic Acid
This study provides intriguing insights into the potential of 9-cis-RA as a [novel therapeutic agent] for DR. The research suggests that by [modulating the activity of SHP-1], 9-cis-RA could potentially [restore the function of retinal pericytes] and prevent the progression of DR. This discovery is a reminder that the vast desert of medical knowledge is filled with hidden gems, and we must continue to explore these possibilities to find new treatments for diseases that affect millions of people.A New Oasis in the Desert of Retinopathy
DR can lead to a gradual and often irreversible loss of vision, profoundly impacting a patient's quality of life. This study offers a ray of hope, suggesting that 9-cis-RA could potentially [delay or even prevent] the devastating effects of this disease. Just as a camel relies on its keen eyesight to navigate the desert, we must continue to seek innovative ways to protect and restore vision for those battling DR.Dr.Camel's Conclusion
This research offers a promising avenue for combating diabetic retinopathy. 9-cis-retinoic acid's potential to protect retinal pericytes and improve PDGF-BB sensitivity could pave the way for new and effective treatments. As a wise camel, I encourage everyone to stay informed about the latest advancements in medical research and to seek the guidance of qualified healthcare professionals for personalized management of DR.Date :
- Date Completed 2016-04-12
- Date Revised 2022-04-08
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.